Namit C.

Namit C. is a seasoned life sciences thought leader with over nine years of experience in the pharmaceutical industry. Currently serving as the Director of Global/US Forecasting and Insights at AstraZeneca, Namit previously led teams in forecasting and analytics for significant portfolios, including a $6 billion Immunology portfolio at GSK and a ~$4 billion surgical products portfolio at Novartis/Alcon. Known for a data-driven commercial strategy, Namit has achieved remarkable results, including forecast accuracy of nearly 90% and identifying unmet patient needs that doubled market opportunities. Namit holds an MBA in Business Administration from the Indian Institute of Management Mumbai.